Experienced operators. Flexible teams.
UBC brings together life science commercial leaders who know how to assess opportunities, build strategy and move quickly into execution.
Built around the work.
We work alongside management teams, boards and investors to add senior commercial capability without the delay and fixed cost of building every function internally.
Senior Operating Team
Experienced executives who lead UBC engagements, shape strategy and assemble the right resources around each client need.
Jeff Whitmore
Founder & President
Jeff is a senior life-science executive and operator with experience building growth, restructuring organizations and bringing emerging technologies to market. His background spans enterprise P&L leadership, commercial and operating strategy, organizational build-out, market development and cross-functional leadership across manufacturing, quality, finance and customer operations. He has also led acquisitions, strategic transactions and board-level value-creation initiatives across life-science tools, diagnostics, services and biomanufacturing.
Terry Salyer
Managing Director
Terry is a senior life-science commercial executive with more than 25 years of experience building global sales organizations and driving growth. She has served repeatedly as Chief Commercial Officer and in senior worldwide sales roles. Through UBC, she served as CEO of ORFLO Technologies, combining commercial strategy, P&L discipline and operating leadership.
Ray Kaczmarek
Executive Director, Operations & Biomanufacturing
Ray is a senior life-science commercial and operating executive with experience building businesses, scaling biomanufacturing and translating customer demand into reliable commercial execution. His background spans enterprise P&L leadership, commercial operations, national accounts, CDMO growth, advanced therapies, CMC, quality, manufacturing, supply and capital deployment. He has held senior leadership roles at Genezen, Nitto Avecia, TriLink and Nanoscope, and as Executive Chairman of Advanced Medicine Partners helped build the commercial business and operating infrastructure while mentoring key leaders. At UBC, Ray connects market strategy, sales execution and customer opportunity with manufacturing readiness, scale-up, supply and delivery.
Carrie Raasch
Senior Director, Commercial Programs & Operations
Carrie brings nearly 20 years of commercial and operating leadership across healthcare and life sciences, spanning global sales and marketing, product management, commercialization and organizational transformation. Her experience includes executive-level operating responsibilities, M&A integration, KPI and commercial-process development, and cross-functional leadership. At UBC, she leads commercial programs from strategy through execution.
Commercial Specialists
UBC adds experienced functional and regional capability as the engagement requires it.
Varshal Dave
Senior Advisor, Marketing & Go-to-Market Strategy
Varshal brings more than two decades of life-science marketing, sales and commercialization experience across emerging and established organizations. He specializes in translating complex technologies into clear positioning, messaging, market segmentation and go-to-market plans, with particular strength in launch strategy and commercial team development.
Monica Errico, PhD
Senior Advisor, Commercial Strategy & Capital
Monica brings more than 25 years of scientific, commercial and strategic experience across life-science tools, diagnostics, biotech and medtech. Her work spans go-to-market strategy, investor readiness, capital strategy and growth planning, helping emerging companies connect strong science with market traction and enterprise value.
Vijay Bhakta
Regional Business Development Manager
Vijay has spent more than 25 years helping introduce disruptive life-science technologies and reposition mature brands into new markets. His experience spans sales, marketing, research, production and quality across biotech, pharma, academic, government and medical-device customers.
Richard “Rick” Stelluto
Regional Business Development Manager
Rick brings decades of life-science commercial experience introducing scientific technologies, developing customer relationships and building sales in U.S. markets. His scientific background in genetics and oncology complements extensive experience supporting emerging instrument and technology companies.
Strategic Partners
UBC works with complementary organizations that extend our market reach, operating capabilities and access to strategic capital.
Orange County Bio
Strategic Commercial Partner
Orange County Bio adds specialized cell and gene therapy expertise to selected UBC engagements. Together, the teams combine commercial strategy, market intelligence, technical depth and execution resources for complex advanced-therapy opportunities.
BroadOak Capital Partners
Strategic Capital & Transaction Relationship
BroadOak Capital Partners brings deep life-sciences investment and transaction expertise across tools, diagnostics and biopharma services. UBC has worked alongside BroadOak on financing and strategic transaction initiatives, adding sector-specific capital and M&A perspective where appropriate.
Novoptim
European Market Development Partner
Novoptim extends UBC’s commercial reach across Europe with an integrated life-science sales and marketing organization. Together, we support European market assessment, positioning, lead generation, business development and localized sales execution.
APG Bio
China Market Development Partner
APG Bio extends UBC’s reach into China through established distribution channels, local market knowledge and experience launching international life-science technologies. The relationship gives clients a practical route to evaluate opportunities and build customer access in the Chinese market.
Sweetgrass Bio
Advanced Therapies & CDMO Strategy Partner
Led by Christy Franco, PhD, Sweetgrass Bio brings deep experience in advanced therapies, biologics and CDMO commercialization. The collaboration expands UBC’s capabilities in manufacturing readiness, technical-commercial strategy, business development and execution across complex biomanufacturing programs.
United BioChannels
Copyright 2026